Keyphrases
Neurodegeneration
100%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
100%
Deregulation
100%
CD40 Ligand (CD40L)
100%
In Cancer
100%
CD40
88%
Cellular Immune Response
44%
T Cells
33%
Cytotoxic T Lymphocytes
33%
Anti-neuroinflammation
22%
Deregulated Expression
22%
Humoral Immune Response
11%
Specific Intent
11%
Molecular Mechanism
11%
CD4+ T Cells
11%
Central Nervous System
11%
Functional Impact
11%
Immune Regulation
11%
Leukemia
11%
Costimulatory Molecules
11%
CD8+ T Cells
11%
Cellular Immunity
11%
Cell Signaling Pathways
11%
Dendritic Cells
11%
Pathway Control
11%
Cancer Disease
11%
Immune Mediators
11%
Adult T-cell Leukemia
11%
Gene Expression
11%
Inflammation
11%
Neurological Diseases
11%
Cytotoxic T Cell Response
11%
Immune Response
11%
Transcriptional Regulation
11%
Therapeutic Strategies
11%
Transcriptional Control
11%
Transcriptional Activation
11%
Infected Cells
11%
Myelopathy
11%
Functional Abnormalities
11%
Functional Maturation
11%
Tropical Spastic Paraparesis
11%
Medicine and Dentistry
Neurodegeneration
100%
Human T-Lymphotropic Virus 1
100%
Malignant Neoplasm
100%
CD40 Ligand
66%
Cytotoxic T-Cell
55%
Cellular Immunity
55%
T Lymphocyte
22%
Leukemia
22%
Diseases
22%
Transcription Initiation
11%
Antivirus Agent
11%
Immunomodulation
11%
Mediator
11%
Receptor
11%
Spinal Cord Disease
11%
Dendritic Cell
11%
Infection
11%
Immune Response
11%
Humoral Immunity
11%
T Cell
11%
Gene Expression
11%
Adult T-Cell Leukemia/Lymphoma
11%
Maturation
11%
Central Nervous System
11%
Neurologic Disease
11%
T-Helper Cell
11%
Tropical Spastic Paraparesis
11%
Immunity
11%
Transactivation
11%
Cell Signaling Pathway
11%
Immunology and Microbiology
Human T-Lymphotropic Virus 1
100%
Human T Cell Leukemia Virus
100%
CD40 Ligand
66%
Adoptive Immunity
55%
T Cell
44%
Cytotoxic T Cell
44%
Transcription Initiation
11%
Dendritic Cell
11%
Cytotoxic T-Cell
11%
Humoral Immunity
11%
Immune Response
11%
Central Nervous System
11%
Gene Expression
11%
T-Helper Cell
11%
Maturation
11%
Mediator
11%
Immunomodulation
11%
Immunity
11%
Transactivation
11%